March 2019 FDA Recall Drug by Legacy Pharmaceutical Packaging Llc
D-1075-2019 - CGMP Deviations

This Class II drug recall was voluntarily initiated by Legacy Pharmaceutical Packaging Llc on March 1, 2019 for the product Drug. The FDA reported the reason for recall as cgmp deviations. The product was distributed in AZ, IN, TN and the recall is currently terminated.

Recall Number: D-1075-2019

Reason for Recall
CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) detected.
Initiated
03-01-2019
Reported
04-10-2019
Quantity
179,544 30-count bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Legacy Pharmaceutical Packaging LLC
Losartan Potassium Tablets, USP, 50 mg, 30 tablet bottles, Rx Only, Distributed by: The Kroger Co, Cincinnati, OH 45202, Manufactured for: Torrent Pharma Inc., 150 Allen Road, Suite 102, Basking Ridge, NJ 07920, Packaged by: Legacy Pharmaceutical Packaging LLC, Earth City, MO 63045 NDC 68645-494-54

Batch or Lot Expiration Information

Lot# Lots: 180190, 180191 (exp 10/2020) and 181597 (exp 02/2021)